Proximagen is a leading neuroscience research company that specializes in the development of drugs for neurodegenerative disorders. With a focus on Parkinson's disease and Alzheimer's disease, Proximagen aims to improve the lives of patients suffering from these debilitating conditions. As a publicly traded organization, Proximagen has achieved significant milestones in its drug development effort...